Seminar on “Clinical Neuroscience and behaviour”
On March 16th, 2016 at noon in the building U8–room 8 at the University of Milano-Bicocca in Monza (Via Cadore, 48) Prof….
New publication on ALS genetics leaded by the ITALSGEN consortium: ATXN2 & C9ORF72
A new paper of the ITALSGEN and SARDINIALS consortia listing some NeuroMI members among participants. Neurobiol Aging. 2015 Dec 8. pii:…
New publication on amyotrophic lateral sclerosis
Neurodegener Dis. 2016 Jan 9. [Epub ahead of print] BDNF Serum Levels with Respect to Multidimensional Assessment in Amyotrophic Lateral Sclerosis….
Visual disturbances in patients with cerebrovascular lesion – Monza, Nov 28th, 2015
Visual disturbances in patients with cerebrovascular lesion: assesssment and rehabilitation Nov 28th, 2015; h. 09.00-17.00 San Gerardo Hospital – Monza; Conference…
- Biotechnology and Nanomedicine
- Clinical Neuroscience
- Cognitive and Behavioural Neuroscience
- Computational and Systems Neuroscience
- Molecular and Cellular Neuroscience
- Neuroimaging and Methodological research
- Uncategorized
NeuroMI has been accepted to be part of the Centres of Excellence within the European Alzheimer’s Disease Consortium (EADC).
I’m glad to announce that the 4th of November, during the EADC General Assembly held in Barcelona, the NeuroMI has been…
- Biotechnology and Nanomedicine
- Clinical Neuroscience
- Computational and Systems Neuroscience
- Molecular and Cellular Neuroscience
- Neuroimaging and Methodological research
8TH CLINICAL TRIALS ON ALZHEIMER’S DISEASE (CTAD 2015), Barcelona, Spain
Thursday, November 5th at 4.45pm, Dr. Piazza Fabrizio will present the latest iCAβ International Network Research News at the 8TH CLINICAL TRIALS ON ALZHEIMER’S…
IMPRS for Brain and Behavior
International Max Planck Research School (IMPRS) for Brain and Behavior offers a competitive world-class Ph.D. training and research program. Our research…
- Biotechnology and Nanomedicine
- Clinical Neuroscience
- Computational and Systems Neuroscience
- Molecular and Cellular Neuroscience
- Neuroimaging and Methodological research
Anti-Aβ autoantibodies in amyloid related imaging abnormalities (ARIA): candidate biomarker for immunotherapy in Alzheimer’s disease and cerebral amyloid angiopathy.
Here is the just released Frontiers of Neurology Review. In the manuscript, we gave an update of all the results of…